FDA Approves METRONIDAZOLE — Alembic Pharmaceuticals Limited

# FDA Approves Alembic Pharmaceuticals' Generic Metronidazole Topical Formulation The U.S. Food and Drug Administration has approved Alembic Pharmaceuticals Limited's abbreviated new drug application (ANDA 212646) for a generic topical metronidazole formulation, expanding the competitive landscape in the dermatological antibiotic market. The approval is expected to increase price competition and improve patient access to this widely-used topical treatment for bacterial infections and rosacea.